Title
Category
Credits
Event date
Cost
  • Diagnostic Tools
  • Sleep
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Sleep experts Drs Roth and Winkelman explore the differential diagnosis and treatment of narcolepsy in this CME journal activity.
  • Adherence
  • Antipsychotics
  • Cognition
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
  • Treatment Resistance
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
New treatments for schizophrenia may improve symptom domains other than positive symptoms and reduce adverse effects. Learn more in this CME activity.
  • Anticonvulsants
  • Antipsychotics
  • Bipolar Disorder
  • Mood Disorders
  • Suicide
  • Violence/Aggression
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
When should you rely on top-ranked treatment options for acute bipolar mania, and when should you skip down to lower-ranked options? Dr Suppes discusses.
  • Anticonvulsants
  • Antipsychotics
  • Bipolar Disorder
  • Mood Disorders
  • Suicide
  • Violence/Aggression
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Dr Suppes discusses guidelines for maintenance treatment of bipolar I disorder, with an algorithm for pharmacologic and psychosocial interventions.
  • Adherence
  • Antipsychotics
  • Psychotherapy
  • Schizophrenia/ Schizoaffective Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
In this CME activity, learn how to use patient-centered care to enhance medication adherence and aid functional recovery in schizophrenia.
  • Antidepressants
  • Anxiety
  • Depression
  • Diagnostic Tools
  • Substance Use Disorders
  • Suicide
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Identification of depression is crucial. Untreated depression is linked to functional impairment and suicide. Earn CME about how measurement-based care.
  • Adherence
  • Antipsychotics
  • Schizophrenia/ Schizoaffective Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What can you do to combat relapse in your patients with schizophrenia? Dr Lauriello discusses identifying and addressing nonadherence to antipsychotics.ABSTRACTMany individuals with schizophrenia experience multiple relapses, which are associated with serious and potentially fatal outcomes. Nonadherence to antipsychotic medications is a major contributor to relapse. By using reliable strategies to measure adherence and identify patients who are not taking their medications as prescribed, clinicians can intervene to possibly prevent relapse or decrease its severity. 
  • Delivery of Care
  • Movement Disorders
  • Neurology
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Measurement-based care has been found to be effective in patients with psychiatric conditions. Learn how to employ MBC for patients with tardive dyskinesia.
  • Diagnostic Tools
  • Sleep
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Which patients need evaluation for excessive daytime sleepiness and central hypersomnias? Dr Winkelman shares his expertise in this brief CME activity.
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Which medications can improve the motor and nonmotor symptoms of Parkinson disease? Dr Isaacson offers strategies to address multiple challenges.

Pages